Tekade RK - Search Results

1

Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Gandhi NS, Tekade RK, Chougule MB. Gandhi NS, et al. Among authors: tekade rk. J Control Release. 2014 Nov 28;194:238-56. doi: 10.1016/j.jconrel.2014.09.001. Epub 2014 Sep 7. J Control Release. 2014. PMID: 25204288 Free PMC article. Review.

2

Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.

Tekade RK, Chougule MB. Tekade RK, et al. Biomed Res Int. 2013;2013:712678. doi: 10.1155/2013/712678. Epub 2013 Sep 11. Biomed Res Int. 2013. PMID: 24106715 Free PMC article.

3

STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells.

Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB. Youngren SR, et al. Among authors: tekade rk. Biomed Res Int. 2013;2013:858946. doi: 10.1155/2013/858946. Epub 2013 Sep 26. Biomed Res Int. 2013. PMID: 24191252 Free PMC article.

4

Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.

Tekade RK, Youngren-Ortiz SR, Yang H, Haware R, Chougule MB. Tekade RK, et al. Mol Pharm. 2014 Oct 6;11(10):3671-83. doi: 10.1021/mp500403b. Epub 2014 Sep 11. Mol Pharm. 2014. PMID: 25179221

5

Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics.

Tekade RK, Tekade M, Kumar M, Chauhan AS. Tekade RK, et al. Among authors: tekade m. Pharm Res. 2015 Mar;32(3):910-28. doi: 10.1007/s11095-014-1506-0. Epub 2014 Sep 10. Pharm Res. 2015. PMID: 25205461

6

Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers.

Ghanghoria R, Kesharwani P, Tekade RK, Jain NK. Ghanghoria R, et al. Among authors: tekade rk. J Control Release. 2018 Jan 10;269:277-301. doi: 10.1016/j.jconrel.2016.11.002. Epub 2016 Nov 11. J Control Release. 2018. PMID: 27840168 Review.

7

Nanomedicines accessible in the market for clinical interventions.

Gadekar V, Borade Y, Kannaujia S, Rajpoot K, Anup N, Tambe V, Kalia K, Tekade RK. Gadekar V, et al. Among authors: tekade rk. J Control Release. 2021 Feb 10;330:372-397. doi: 10.1016/j.jconrel.2020.12.034. Epub 2020 Dec 25. J Control Release. 2021. PMID: 33370576 Review.

8

Micro- and nanocarrier-mediated lung targeting.

Kurmi BD, Kayat J, Gajbhiye V, Tekade RK, Jain NK. Kurmi BD, et al. Among authors: tekade rk. Expert Opin Drug Deliv. 2010 Jul;7(7):781-94. doi: 10.1517/17425247.2010.492212. Expert Opin Drug Deliv. 2010. PMID: 20560777 Review.

9

Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders.

Maheshwari R, Tekade M, Sharma PA, Tekade RK. Maheshwari R, et al. Among authors: tekade rk, tekade m. Curr Pharm Des. 2015;21(30):4427-40. doi: 10.2174/138161282130151007150300. Curr Pharm Des. 2015. PMID: 26471319 Review.

10

siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector.

Tekade RK, Maheshwari RG, Sharma PA, Tekade M, Chauhan AS. Tekade RK, et al. Among authors: tekade m. Curr Pharm Des. 2015;21(31):4614-36. doi: 10.2174/138161282131151013192116. Curr Pharm Des. 2015. PMID: 26486147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page